Search

1. Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Author(s):

Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021

Subject(s):

Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States

2. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

Author(s):

Beaudoin, Francesca L., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Yeung, Kai, 1981- author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David M., author
Lin, Grace A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of School of Pharmacy, University of Colorado), author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 23, 2023

Subject(s):

Cost-Effectiveness Analysis
Heterocyclic Compounds, 2-Ring
Hot Flashes
Menopause
Thiadiazoles
Vasomotor System
United States

3. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report

Author(s):

Tice, Jeffrey A., author
Chu, Janet N., author
Moradi, Ashton, author
Herce-Hagiwara, Belen, author
Fahim, Shahariar Mohammed, author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Walton, Surrey M., author
Sarker, Jyotirmoy, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 22, 2022

Subject(s):

Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Cost-Effectiveness Analysis
Genetic Therapy
Hemophilia A -- therapy
Hemophilia B -- therapy
United States

4. Medications for obesity management: effectiveness and value : final evidence report

Author(s):

Atlas, Steven J., author
Beinfeld, Molly, author
Lancaster, Victoria, author
Nhan, Emily, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Beaudoin, Francesca L., author
Kim, Kibum, author
Lien, Pei-Wen, author
Shah, Kanya, author
Touchette, Daniel R., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2022

Subject(s):

Bupropion
Glucagon-Like Peptide-1 Receptor Agonists
Liraglutide
Obesity -- drug therapy
Obesity Management -- methods
Phentermine
United States

5. Novel agents to prevent chemotherapy-induced neutropenia and other myelosuppressive effects: revised evidence report

Author(s):

Tice, Jeffrey A., author
McKenna, Avery, author
Herce-Hagiwara, Belén, author
Moradi, Ashton, author
Pearson, Steven D., author
Ollendorf, Daniel A., author
Bloudek, Lisa, author
Carlson, Josh J., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 17, 2022

Subject(s):

Antineoplastic Agents -- adverse effects
Chemotherapy-Induced Febrile Neutropenia -- drug therapy
Chemotherapy-Induced Febrile Neutropenia -- prevention & control
Neutropenia -- drug therapy
Neutropenia -- prevention & control
United States

6. Tirzepatide for type 2 diabetes: final report

Author(s):

Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022

Subject(s):

Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States